• Total testosterone • Bioavailable testosterone • Free testosterone
www.fantamag.com
www.fantamag.com
www.musculardevelopment.com December 2008
314
MDtestosterone
steroid receptors in human prostate. Best
Pract Res Clin Endocrinol Metab, 2008
Apr;22(2):223-8.
6. Goutou M, Sakka C, et al. AR CAG repeat length is not associated with serum gonadal steroids and lipid levels in healthy men. Int J Androl, 2008 Jul 24. [Epub ahead of print]
7. Leifke E, Gorenoi V, et al. Age-related changes of serum sex hormones, insulin- like growth factor-1 and sex-hormone binding globulin levels in men: cross-sec- tional data from a healthy male cohort.
Clin Endocrinol, (Oxf) 2000 Dec;53(6):689-
95.
8. Cohen J, Collins R, et al. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr, 2007 Oct 11;4:12.
9. Bhasin S, Cunningham GR, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guide- line. J Clin Endocrinol Metab, 2006 Jun;91(6):1995-2010.
10. Delany, Joseph. “Omission.” The Catholic Encyclopedia. Vol. 11. New York: Robert Appleton Company, 1911. Available online at
http://www.newadvent.org/cathen/11251b. htm, accessed September 23, 2008.
11. Morgantaler A. Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer.
J Sex Med, 2008 Aug;5(8):1834-40.
12. Debing E, Peeters E, et al. Men with atherosclerotic stenosis of the carotid artery have lower testosterone lev- els compared with controls. Int Angiol, 2008 Apr;27(2):135-41.
13. Bain J. The many faces of testos- terone. Clin Interv Aging, 2007;2(4):567-76.
14. Ellis JA, Sinclair R, et al.
Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol
Med, 2002 Nov 19;4(22):1-11.
15. Lazala C, Saenger P. Pubertal gynecomastia. J Pediatr Endocrinol
Metab, 2002 May;15(5):553-60.
16. Scott MJ 3rd, Scott AM. Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis, 1992 Aug;50(2):113-6.
17. Narula HS, Carlson HE. Gynecomastia. Endocrinol Metab Clin
North Am, 2007 Jun;36(2):497-519.
18. Ersoz H, Onde ME, et al. Causes of
gynaecomastia in young adult males and factors associated with idiopathic gynae- comastia. Int J Androl, 2002 Oct;25(5):312- 6.
19. Amory JK, Bremner WJ. Regulation of testicular function in men: implications for male hormonal contraceptive develop- ment. J Steroid Biochem Mol Biol, 2003 Jun;85(2-5):357-61.
20. Meyer E. Patient wait times: bumped by botox? Skin & Aging, 2007;15:42-44.
21. American Society of Plastic Surgeons. Top 5 Surgical Cosmetic Procedures in 2007. Available online at http://www.plasticsurgery.org/media/statis tics/loader.cfm?url=/commonspot/security/ getfile.cfm&PageID=29288, accessed September 23, 2008.
22. Khaw KT, Dowsett M, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC- Norfolk) Prospective Population Study.
Circulation, 2007 Dec 4;116(23):2694-701.
23. Choi BG, McLaughlin MA. Why men’s hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin
North Am 2007 Jun;36(2):365-77.
24. Jones RD, Nettleship JE, et al. Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs, 2005;5(3):141-54.
25. Beauchet O. Testosterone and cog- nitive function: current clinical evidence of a relationship. Eur J Endocrinol, 2006 Dec;155(6):773-81.
26. Bhasin S, Woodhouse L, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal mus- cle. J Clin Endocrinol Metab, 2005 Feb;90(2):678-88.
27. Coviello AD, Kaplan B, et al. Effects of graded doses of testosterone on ery- thropoiesis in healthy young and older men. J Clin Endocrinol Metab, 2008 Mar;93(3):914-9.
28. Chandel A, Dhindsa S, et al. Testosterone concentrations in young patients with diabetes mellitus. Diabetes
Care, 2008 Jul 23. [Epub ahead of print]
29. Loves S, Ruinemans-Koerts J, et al. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. Eur J Endocrinol, 2008 May;158(5):741-7.
30. Kelestimur F, Tanriverdi F, et al. Boxing as a sport activity associated with isolated GH deficiency. J Endocrinol
Invest, 2004 Dec;27(11):RC28-32.
31. Kelestimur F. Chronic trauma in sports as a cause of hypopituitarism.
Pituitary, 2005;8(3-4):259-62.
32. Ives JC, Alderman M, et al. Hypopituitarism after multiple concus- sions: a retrospective case study in an adolescent male. J Athl Train, 2007 Jul- Sep;42(3):431-9.
33. Bonefeld-Jorgensen EC, Long M, et al. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review.
Environ Health Perspect, 2007 Dec;115
Suppl 1:69-76.
34. Vermeulen A. Androgen replace- ment therapy in the aging male – a critical evaluation. J Clin Endocrinol Metab, 2001;86:2380-90.
35. Laughlin GA, Barrett-Connor E, et al. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab, 2008 Jan;93(1):68-75.
36. Araulo AB, O’Donnell AB, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab, 2004 Dec;89(12):5920-6.
37. Travison TG, Araulo AB, et al. A population-level decline in serum testos- terone levels in American men. J Clin
Endocrinol Metab, 2007 Jan;92(1):196-202.
38. Tan RS. Andropause: introducing the concept of ‘relative hypogonadism’ in aging males. Int J Impot Res, 2002 Aug;14(4):319.
39. Parkhill T. Global menopause sum- mit concludes HRT is safe for healthy women entering menopause. Available online at
http://www.eurekalert.org/pub_releases/20 08-05/ims-gms051508.php, accessed September 23, 2008.
40. Lehnhardt M, Homann HH, et al. Major and lethal complications of liposuc- tion: a review of 72 cases in Germany between 1998 and 2002. Plast Reconstr
Surg, 2008 Jun;121(6):396e-403e.
41. Mulligan T, Frick MF, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int
J Clin Pract, 2006 Jul;60(7):762-9.
www.fantamag.com
www.fantamag.com
utstanding quadriceps sepa- ration demands freakish thigh mass that dives into deep canyons etched on either side of the muscle bellies. When it comes to top thighs, it is hard not to think about the mass and cross-striations of a shredded Jay Cutler, or the size and shape of a ripped-to-the-bone Ronnie Coleman. This kind of thigh development initially relies on regu- lar back squats and leg presses to build great mass builders. However, as good of a mass builder as these exercises are, they simply do not get the job done when it comes to devel- oping thigh separation and cuts. Achieving those deep separations requires exercises that build mass by targeting each of the bellies under near-constant tension and this means some specialization work for the middle and the lower quadriceps.
You probably are drawn to thinking about leg extensions for ripping your thigh mass. However, if you are willing to handle the work, the barbell lunge is an alternative and intensive way to blast a bulky thigh into strips of carved, sharp and lean mass. As a byproduct, lunges will greatly improve your quadriceps, hamstrings and gluteal power and endurance and this will come in pretty handy when you start your heavy squat sessions for adding even greater overall mass. To do lunges properly, you must rise above the crowd who is satisfied
with a few sets of leg extensions to tighten the quadriceps. Lunges are only for the serious lifter who is willing to push well through the pain barrier into the valley of unbelievable thighs. Three sets of these will take your thighs to new contours, valleys and grooves that you did not know existed.